Anti-proliferative effects of O-acyl-low-molecular-weight heparin derivatives on bovine pulmonary artery smooth muscle cells

Glycoconjugate Journal

Volumn 28, Issue 6, 2011, Pages 419-426

  Garg, Hari G ^a   Mrabat, Hicham ^a   Yu, Lunyin ^a   Hales, Charles A ^a   Li, Boyangzi ^b   Moore, Casey N ^b   Zhang, Fuming ^b   Linhardt, Robert J ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

Heparin; Low molecular weight heparin; O acylated; Smooth muscle cells; Surface plasmon resonance

Indexed keywords

BUTYRIC ACID; CARBON; DECANOIC ACID; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; HEXANOIC ACID; LAURIC ACID; LOW MOLECULAR WEIGHT HEPARIN; OCTANOIC ACID; PERIODATE SODIUM; SODIUM BOROHYDRIDE; STEARIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CATTLE DISEASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; IN VITRO STUDY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PULMONARY ARTERY; SMOOTH MUSCLE FIBER;

ANIMALS; CARBOHYDRATE SEQUENCE; CATTLE; CELL PROLIFERATION; CELLS, CULTURED; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; INHIBITORY CONCENTRATION 50; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; MYOCYTES, SMOOTH MUSCLE; PULMONARY ARTERY;

BOVINAE;

EID: 80054767321     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-011-9341-6     Document Type: Article

References (34)

1. Hales, C. A., Kradin, R. L., Branstetter, R. D., Zhu, Y. J.: Impairment of hypoxic pulmonary artery remodeling by heparin in mice. Am. Rev. Respir. Dis. 128, 747-751 (1983) (Pubitemid 13014131)
2. Hislop, A., Reid, L.: New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Br. J. Exp. Pathol. 57, 542-554 (1976)
3. Owens, G. K.: Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75, 487-517 (1995)
4. Runo, J. R., Loyd, J. E.: Primary pulmonary hypertension. Lancet. 361, 1533-44 (2003) (Pubitemid 36566349)
5. Garg, H. G., Mrabat, H., Yu, L., Freeman, C., Li, B., Zhang, F., Linhardt, R. J., Hales, C. A.: Significance of the 2-O-sulfo group of L-iduronic acid residues in heparin on the growth inhibition of bovine pulmonary artery smooth muscle cells. Carbohydr. Res. 343, 2406-10 (2008)
6. Guyton, J. R., Rosenberg, R. D., Clowes, A. W., Karnovsky, M. J.: Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin. Circ. Res. 46, 625-34 (1980) (Pubitemid 10096678)
7. Castellot Jr., J. J., Cochran, D. L., Karnovsky, M. J.: Effect of heparin on vascular smooth muscle cells. I. Cell metabolism. J. Cell Physiol. 124, 21-8 (1985) (Pubitemid 15042634)
8. Lovich, M. A., Edelman, E. R.: Tissue concentration of heparin, not administered dose, correlates with the biological response of injured arteries in vivo. Proc. Natl. Acad. Sci. USA 96, 11111-6 (1999) (Pubitemid 29487342)
9. Edelman, E. R., Karnovsky, M. J.: Contrasting effects of the intermittent and continuous administration of heparin in experimental restenosis. Circulation. 89, 770-6 (1994) (Pubitemid 24056205)
10. Welt, F. G., Woods, T. C., Edelman, E. R.: Oral heparin prevents neointimal hyperplasia after arterial injury: inhibitory potential depends on type of vascular injury. Circulation. 104, 3121-4 (2001) (Pubitemid 34014068)
11. Ofosu, F. A., Danishefsky, I., Hirsh, J. (Eds.): Heparin and related polysaccharides. Ann. N. Y. Acad. Sci. vol. 556, (1989)
12. Robenstein, D. L.: Heparin and heparan sulfate: structure and function. Nat. Prod. Rep. 19, 312-331 (2002)
13. Casu, B.: Structure and biological activity of heparin. Adv. Carbohydr. Chem. Biochem. 43, 51-134 (1985)
14. Hileman, R. E., Fromm, J. R., Weiler, J. M., Linhardt, R. J.: Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. BioEssays. 20, 156-167 (1998) (Pubitemid 28132111)
15. Dahlberg, C. G. W., Thompson, B., Joseph, P. M., Garg, H. G., Spence, C. R., Quinn, D. A., Boventre, J. V., Hales, C. A.: Differential effect of three commercial heparins on Na+/H+exchange and growth of PASMC. Am. J. Physiol. 270, 260-265 (1996)
16. Joseph, P. A. M., Garg, H. G., Thompson, T., Liu, X., Hales, C. A.: Influence of molecular weight, protein core and charge of native heparin fractions on pulmonary artery smooth muscle cell proliferation. Biochem. Biophys. Res. Commun. 241, 18-23 (1997) (Pubitemid 28033532)
17. Garg, H. G., Yu, L., Hales, C. A., Toida, T., Toshi, T., Capila, I., Linhardt, R. J.: Effect of fully sulfated glycosaminoglycans on pulmonary artery smooth muscle cell proliferation Arch. Biochem. Biophys. 371, 228-233 (1999)
18. Longas, M. O., Garg, H. G., Trinkle-Pereira, J. M., Hales, C. A.: Heparin antiproliferative activity on bovine pulmonary artery smooth muscle cells requires both N-acetylation and N-sulfonation. Carbohydr. Res. 338, 251-256 (2003) (Pubitemid 36120701)
19. Garg, H. G., Yu, L., Hales, C. A., Toida, T., Islam, T., Linhardt, R. J.: Sulfation patterns in heparin and heparan sulfate: effects on the proliferation of bovine pulmonary artery smooth muscle cells. Biochim. Biophys. Acta. 1639, 225-231 (2003) (Pubitemid 37421429)
20. Garg, H. G., Hales, C. A., Yu, L., Butler, M., Islam, T., Xie, J., Linhardt, R. J.: Increase in the growth inhibition of bovine pulmonary artery smooth muscle cells by an O-hexanoyl lowmolecular-weight heparin derivative. Carbohydr. Res. 341, 2607-2612 (2006) (Pubitemid 44427785)
21. Matsuda, T., Magoshi, T.: Terminally alkylated heparin. 1. Antithrombogenic surface modifier. Biomacromol. 2, 1169-1177 (2001) (Pubitemid 34026894)
22. Gohda, M., Magoshi, T., Kato, S., Noguchi, T., Yasuda, S., Nonogi, H., Matsuda, T.: Terminally alkylated heparin. 2. Potent antiproliferative agent for vascular smooth muscle cells. Biomacromol. 2, 1178-1183 (2001) (Pubitemid 34026895)
23. Bârzu, T., Desmoulière, A., Herbert, J. M., Level, M., Herault, J. P., Petitou, M., Lormeau, J. C., Gabbiani, G., Pascal, M.: O-acylated heparin derivatives with low anticoagulant activity decrease proliferation and increase alpha-smooth muscle actin expression in cultured arterial smooth muscle cells. Eur. J. Pharmacol. 219, 225-33 (1992)
24. Pukac, L. A., Hirsch, G. M., Lormeau, J. C., Petitou, M., Choay, J., Karnovsky, M. J.: Antiproliferative effects of novel, nonanticoagulant heparin derivatives on vascular smooth muscle cells in vitro and in vivo. Am. J. Pathol. 139, 1501-1509 (1991)
25. Islam, T., Butler, M., Sikkander, S. A., Toida, T., Linhardt, R. J.: Further evidence that periodate cleavage of heparin occurs primarily through the antithrombin binding site. Carbohydr. Res. 337, 2239-2243 (2002) (Pubitemid 35335872)
26. Edens, R. E., Al-Hakim, A., Weiler, J. M., Rethwisch, D. G., Fareed, J., Linhardt, R. J.: Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives. J. Pharm. Sci. 81, 823-827 (1992) (Pubitemid 23006826)
27. Hernaiz, M., Liu, J., Rosenberg, R. D., Linhardt, R. J.: Enzymatic modification of heparan sulfate on a biochip promotes its interaction with antithrombin III. Biochem. Biophys. Res. Commun. 276, 292-297 (2000)
28. Underwood, P. A., Mitchell, S. M., Whitelock, J. M.: Heparin fails to inhibit the proliferation of smooth muscle cells in the presence of human serum. J. Vasc. Res. 35, 449-460 (1998) (Pubitemid 29051018)
29. Saivin, S., Petitou, M., Lormeau, J. C., Dupouy, D., Sié, P., Caranobe, C., Houin, G., Boneu, B.: Pharmacologic properties of an unfractionated heparin butyryl derivative with long-lasting effects. J. Lab. Clin. Med. 119, 189-96 (1992)
30. Ornitz, D. M., Itoh, N.: Fibroblast growth factors. Genome Biol. 2, 1-12 (2001)
31. Ornitz, D. M.: FGFs, heparan sulfate and FGFRs: complex interactions essential for development. BioEssays 22, 108-112 (2000) (Pubitemid 30092077)
32. Pellegrini, L.: Role of heparan sulfate in fibroblast growth factor signaling: a structural view. Curr. Opin. Struct. Biol. 11, 629-634 (2001) (Pubitemid 32972028)
33. Lindner, V., Reidy, M. A.: Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against fibroblast growth factor. Proc. Natl. Acad. Sci. USA 88, 3739-3743 (1991) (Pubitemid 21916699)
34. Ghiselli, G., Chen, J., Kaou, M., Hallak, H., Rubin, R.: Ethanol inhibits fibroblast growth factor-induced proliferation of aortic smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 23, 1808-13 (2003) (Pubitemid 37254867)